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Antifungal proteins (AFPs) from Ascomycetes are small cysteine-rich proteins that are
abundantly secreted and show antifungal activity against non-producer fungi. A gene
coding for a class B AFP (AfpB) was previously identified in the genome of the plant
pathogen Penicillium digitatum. However, previous attempts to detect the AfpB protein
were not successful despite the high expression of the corresponding afpB gene. In
this work, the structure of the putative AfpB was modeled. Based on this model, four
synthetic cysteine-containing peptides, PAF109, PAF112, PAF118, and PAF119, were
designed and their antimicrobial activity was tested and characterized. PAF109 that
corresponds to the γ-core motif present in defensin-like antimicrobial proteins did not
show antimicrobial activity. On the contrary, PAF112 and PAF118, which are cationic
peptides derived from two surface-exposed loops in AfpB, showed moderate antifungal
activity against P. digitatum and other filamentous fungi. It was also confirmed that
cyclization through a disulfide bridge prevented peptide degradation. PAF116, which is
a peptide analogous to PAF112 but derived from the Penicillium chrysogenum antifungal
protein PAF, showed activity against P. digitatum similar to PAF112, but was less active
than the native PAF protein. The two AfpB-derived antifungal peptides PAF112 and
PAF118 showed positive synergistic interaction when combined against P. digitatum.
Furthermore, the synthetic hexapeptide PAF26 previously described in our laboratory
also exhibited synergistic interaction with the peptides PAF112, PAF118, and PAF116,
as well as with the PAF protein. This study is an important contribution to the mapping
of antifungal motifs within the AfpB and other AFPs, and opens up new strategies for
the rational design and application of antifungal peptides and proteins.
Keywords: antimicrobial peptides, antifungal proteins, protein mapping, peptide design, Penicillium digitatum,
postharvest pathology, Penicillium chrysogenum, synergy
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INTRODUCTION
There is an urgent need to develop new antifungal molecules
with properties and mechanisms of action different from existing
ones (Brown et al., 2012; Fisher et al., 2012). Antimicrobial
peptides and proteins (AMPs) have been found in a broad
variety of species (Hancock and Sahl, 2006) and are candidates
for the development of novel therapeutic compounds (Zasloff,
2002; Brogden, 2005; Fjell et al., 2012) including antifungals
(Shah and Read, 2013). A remarkable group of AMPs are the
antifungal proteins (AFPs) of fungal origin. AFPs belong to the
broad class of defensins and are produced by some species of
filamentous Ascomycetes, mostly from the genus Aspergillus and
Penicillium (Marx et al., 2008; Meyer, 2008; Galgóczy et al., 2010;
Silva et al., 2014). AFPs are small (∼50 amino acid residues),
secreted, amphipathic, cationic and cysteine-rich proteins (CRPs)
that contain six to eight cysteine residues and fold into
compact disulfide-stabilized structures with five β-strands, which
confer high stability under adverse biochemical and biophysical
conditions (Batta et al., 2009). All the AFPs contain the
so-called γ-core, a three-dimensional peptide signature present
in antimicrobial CRPs spanning biological kingdoms (Yount and
Yeaman, 2004). One of the most studied AFPs is the Penicillium
chrysogenum PAF protein (55 amino acids in length) that can
be easily purified from the culture supernatants of the producer
fungus P. chrysogenum (Marx et al., 2008). PAF inhibits the
growth of filamentous human and plant pathogenic fungi at
µM concentrations and is non-toxic to mammalian cells in vitro
(Marx et al., 2008) and in vivo (Palicz et al., 2013).
A significant diversity of AFP-like genes and proteins are
widespread in Ascomycetes, with genomes that encode up to
three different sequence-related AFPs (Galgóczy et al., 2013;
Garrigues et al., 2016; Tóth et al., 2016), providing a rich source of
potentially divergent antifungals. Bioinformatic and phylogenetic
analyses suggested the classification of the different AFP-like
sequences in at least three different classes: A, B, and C (Garrigues
et al., 2016). Notably, these fungal genomes code for a different
number of AFP-like proteins that belong to diverse classes;
P. chrysogenum encodes three classes (A, B, and C), Penicillium
roqueforti two classes (A and C), and Penicillium digitatum just
one (B). There is also a significant variation in the amount of AFP
produced by each fungus and the growth conditions required
to achieve maximum yields. Thus, the above-mentioned PAF
protein is secreted in large amounts by P. chrysogenum (Marx
et al., 2008), while the NFAP and NFAP2 from Neosartorya
fischeri are produced in modest amounts (Kovács et al., 2011;
Virágh et al., 2014). An extreme example of this scenario is that of
the previously characterized afpB gene identified in the genome
of the phytopathogenic fungus P. digitatum (Garrigues et al.,
2016). Attempts to identify the class B AFP (AfpB) in the small
size protein fraction secreted by the fungus were not successful,
even in the constitutive expressing strains that produce up to
1,000 times more afpB mRNA than the wild-type (Garrigues et al.,
2016). This unexpected finding was one of the main reasons that
led us to conduct the study reported here.
In-depth understanding of the structure and mode of action
of AFPs is required for their potential future application
as antifungal compounds. In addition, AFP and AFP-like
sequences are a rich source for the identification and rational
design of novel antimicrobial peptides with improved properties
(Marcos et al., 2008, 2012). Finally, the structural domains
that account for the antifungal activity of AFPs remain to be
fully identified and characterized. In this study, the structure
of the putative P. digitatum AfpB protein was predicted by
in silico molecular modeling to aid in the design of peptides
based on the AfpB primary sequence and structure, whose
antifungal activity was demonstrated and characterized. With
this rational approach, peptides that have moderate but specific
antifungal activity were identified within the AfpB and PAF
amino acid sequences. Importantly, the previously characterized
PAF26 hexapeptide (Muñoz et al., 2013a) showed positive
synergistic interaction with the AFP-derived peptides and the
PAF protein.
MATERIALS AND METHODS
Strains and Media
The fungal strains used in this study are P. digitatum CECT20796,
P. chrysogenum Q176, Botrytis cinerea CECT2100, Fusarium
oxysporum 4287, and Aspergillus niger CBS 120.49. Fungi were
cultured on potato dextrose agar (Difco-BD Diagnostics, Sparks,
MD, USA) plates for 7–10 days at 24◦C with the exception of
F. oxysporum, which was cultured on potato dextrose broth (PDB;
Difco-BD Diagnostics) at 28◦C for 4 days with shaking. Conidia
(mitotic asexual spores) were collected, filtered, and adjusted
to the appropriate concentration. For antibacterial assays, the
Gram-negative bacterium Escherichia coli JM109 was grown in
Luria-Bertani (LB) medium at 37◦C with shaking.
In silico Calculations and AfpB Structure
Prediction
The SWISS-MODEL program1 (Arnold et al., 2006) was used to
predict the 3D structure of the P. digitatum antifungal protein
AfpB (Garrigues et al., 2016) using the P. chrysogenum antifungal
protein PAF as template (PDB ID 2MHV; Fizil et al., 2015).
The model obtained was refined using the ModRefiner tool2 (Xu
and Zhang, 2011) and subsequently validated by RAMPAGE3 to
ensure that all the amino acids of the AfpB model were located
inside the favored and energetically allowed regions according to
the Ramachandran plot (Lovell et al., 2003).
The theoretical molecular mass, the pI, and the GRAVY of
the mature AfpB protein and peptides derived therefrom were
examined with the Compute pI/Mw and ProtParam tools of the
ExPASy Proteomics Server4 (Gasteiger et al., 2005), respectively.
The signal peptide and disulfide bridges of the mature protein
were predicted using the SignalP 4.0 Server5 (Petersen et al., 2011)
1http://swissmodel.expasy.org/
2http://zhanglab.ccmb.med.umich.edu/ModRefiner/
3http://mordred.bioc.cam.ac.uk/~rapper/rampage.php
4http://web.expasy.org
5http://www.cbs.dtu.dk/services/SignalP/
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and the DISULFIND software6 (Ceroni et al., 2006), respectively.
The 3D model of AfpB was visualized by Chimera software
(Pettersen et al., 2004).
PAF Protein and Synthetic Peptides
The PAF protein was produced by P. chrysogenum and purified
as previously described (Batta et al., 2009; Sonderegger et al.,
2016). All the peptides used in this work were synthetic and
purchased at >95% purity from GenScript (Piscataway, NJ,
USA) wherein they were synthesized by solid phase methods
using N-(9-fluorenyl) methoxycarbonyl (Fmoc) chemistry. The
sequences of the peptides used and their physicochemical
properties are listed in Table 1. Peptides PAF109, PAF112,
PAF118, and PAF119 derived from the AfpB protein, and peptide
PAF116 derived from the PAF protein, were synthetized with
a disulfide bond linking the two cysteine residues, respectively.
Stock solutions of peptides were prepared at 5.12 mM in 10 mM
3-(N-morpholino)-propanesulfonic acid (MOPS; Sigma-Aldrich,
St. Louis, MO, USA) pH 7 and stored at −20◦C. The peptide
concentrations were prepared by dissolving a given peptide
amount (mg) in MOPS buffer (mL), considering the purity of
each of the peptides provided by the manufacturer. Additionally,
the PAF26 concentration was confirmed spectrophotometrically
by measuring the absorbance at 280 nm (ε280= 5600 M−1 cm−1
for W residue).
ECD Spectroscopy
Electronic circular dichroism (ECD) spectroscopic measure-
ments were performed in the 195–260 nm wavelength range (far-
UV) to determine the secondary structure of the AfpB-derived
peptides. Peptide samples were dissolved in H2O, and in a 50:50
trifluoroethanol (TFE):H2O mixture at approximately 0.1 mg/mL
concentration and measured in a 0.1 cm path-length quartz
cuvette using a Jasco J-815 spectropolarimeter at a scan speed of
100 nm/s at 25◦C. Solvent spectra were measured similarly and
subtracted from the corresponding spectra of peptides. Ellipticity
data were given in mdeg units.
Antimicrobial Activity Assays
Growth inhibition assays were performed in 96-well microtiter
plates (Nunc, Roskilde, Denmark) in a total volume of 100 µL
6http://disulfind.dsi.unifi.it/
as described previously (López-García et al., 2002). A volume
of 90 µL of fungal conidia (2.5 × 104 conidia/mL) or bacterial
cells (5 × 105 cells/mL) in appropriate growth media [1/20
diluted PDB containing 0.01% (w/v) chloramphenicol for fungi
or 1/10 diluted LB for bacteria] was mixed in each well with
10 µL of 10× concentrated peptide or PAF protein solution
from serial twofold dilutions (from 1 to 128 µM for PAF109,
PAF112, PAF113, PAF116, PAF118, and PAF119; from 0.25
to 4 µM for PAF26; and from 1 to 16 µM for the protein
PAF from P. chrysogenum). All samples were prepared in
triplicate. Plates were statically incubated for 72 h at the optimal
temperature of each microorganism. Growth was determined
by measuring the optical density (OD) at 600 nm (OD600)
using a Multiskan Spectrum plate spectrophotometer (Thermo
Electron Corporation, Vantaa, Finland), and the OD600 mean
and SD were calculated. Dose–response curves were generated
from measurements after 72 h for fungi, and 48 h for E. coli.
These experiments were repeated at least twice. The minimum
inhibitory concentration (MIC) is the peptide concentration that
completely inhibited growth in all the experiments performed.
For assays of synergy, different combinations of peptides
and concentrations were tested in 96-well microtiter plates. Ten
microliters of two different 10× concentrated peptides were
mixed in the same well with 80 µL of P. digitatum conidia
prepared and grown as above (total volume 100 µL). Plates
were statically incubated for 72 h at 24◦C. Data are expressed
as OD600 mean ± SD of three replicates. Sub-MICs for each
peptide were: 1–32 µM for PAF112, 1–16 µM for PAF118,
1–8 µM for PAF116, and 0.25–2 µM for PAF26. Similarly, the
interaction between the PAF protein from P. chrysogenum and
the PAF26 peptide was tested against A. niger, P. chrysogenum,
and P. digitatum.
Proteolytic Digestion Assays
The proteolytic digestion assays were performed as described
(Ferre et al., 2006; López-García et al., 2015) with minor
modifications. Peptides (5 µM) were dissolved in 10 mM MOPS
pH 7 and digested with 5 µg/mL of recombinant proteinase
K (2 U/mg; Roche, Mannheim, Germany) at 30◦C. Aliquots
were withdrawn from the reaction mixtures at 0, 1, 2, and 24 h
of incubation and immediately heated at 80◦C for 10 min to
inactivate the enzyme. Two replicates were prepared for each
treatment, and the experiments were repeated at least twice.
TABLE 1 | Amino acid sequences and properties of the peptides used in this study.
ID Sequence1 MM (Da) Net charge pI GRAVY Source
PAF26 RKKWFW 950.2 3.0 11.2 −1.883 López-García et al., 2002
PAF109 GQCSLKHNTCT 1189.3 1.1 8.1 −0.718 AfpB (P. digitatum)
PAF112 NCGSAANKRAKSDRHHCE 1982.1 2.2 8.9 −1.600 AfpB (P. digitatum)
PAF113 NAGSAANKRAKSDRHHAE 1920.0 2.2 10.0 −1.678 AfpB (P. digitatum)
PAF118 NTCTYLKGGRNVIVNCG 1810.1 2.0 8.9 −0.065 AfpB (P. digitatum)
PAF119 HCEYDEHHRRVDCQ 1824.9 −1.7 5.8 −2.014 AfpB (P. digitatum)
PAF116 KCPKFDNKKATKDNNKCT 2081.4 4.0 9.5 −1.906 PAF (P. chrysogenum)
1Underlined cysteine residues in PAF109, PAF112, PAF116, PAF118, and PAF119 are linked by disulfide bonds.
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Analyses of peptide digests were conducted by RP-HPLC
using a Waters system (Waters Corporation, Milford, MA, USA)
equipped with a 1525 Binary HPLC pump, a 2996 Photodiode
Array Detector, and a 717 plus Autosampler. A Symmetry C18
column (4.6 mm × 150 mm, 5 µm, Waters Corporation) kept
at 40◦C was operated at a flow rate of 1 mL/min. Peptides were
eluted with a linear gradient of solvent B [acetonitrile with 0.1%
trifluoroacetic acid (TFA)] in solvent A (water with 0.1% TFA)
0–40% in 20 min and detected at 214 nm.
Statistical Analysis
All the statistical analyses carried out to determine the synergistic
interactions were performed using STATGRAPHICS Centurion
16.1.177. The significant differences between sets of data were
determined by a bi-factorial ANOVA and Tukey’s honestly
significant difference (HSD) test. Significance was regarded as
p< 0.01.
RESULTS
AfpB Structural Modeling
In silico translation of the afpB gene (PDIG_68840) shows that
the AfpB primary structure contains 92 amino acid residues
(Garrigues et al., 2016). A signal peptide and a pro-peptide (35
residues in total) are predicted to be cleaved from the N-terminal
end of the protein, liberating the mature AfpB which is a small
basic CRP consisting of 57 amino acid residues (Figure 1A). It
has a calculated molecular mass of 6.46 kDa, a pI value of 9.06
and a GRAVY of −1.084. The dextromeric isoform of the γ-core
with the consensus sequence GXCX3−9C (Yount and Yeaman,
2004) is present near the N-terminus (Figure 1A, boxed). The
structure of mature AfpB was predicted by homology modeling
7http://www.statgraphics.com/
using the SWISS-MODEL online resource, which selected the
protein PAF from P. chrysogenum as template for prediction
(PDB ID 2MHV; Fizil et al., 2015), and refined using the
ModRefiner tool (Figure 1). AfpB shows 33% amino acid identity
and 44% similarity with the P. chrysogenum PAF. The refined
AfpB model showed 56 of 57 (98%) of the amino acid residues
positioned in energetically favored regions and one residue in
energetically allowed regions according to the Ramachandran
plot (Supplementary Figure S1). The structural model of AfpB
contains five antiparallel β-strands connected by three small
loops and a big surface-exposed loop (Supplementary Figure
S2 and Figure 1). The antiparallel β-strands create two packed
β-sheets and the six conserved cysteine residues form three
disulfide bridges. The most probable disulfide bond pattern
predicted by the DISULFIND software is “abcabc,” between
cysteines 7 and 35; 14 and 42; and 27 and 53 (see also Figure 2A),
which also corresponds to the disulfide bond pattern determined
in PAF (Váradi et al., 2013).
Identification of AfpB-Derived Antifungal
Peptides with Specific Antifungal Activity
To identify putative antimicrobial motifs in AfpB, the cysteine-
containing peptides PAF109, PAF112, PAF118, and PAF119 were
derived from the AfpB sequence (Table 1). Peptides (Figure 2A)
were rationally designed with intramolecular disulfide bonds to
promote folding into a loop or β-hairpin structure corresponding
to the regions within the protein (Figure 2B). Peptide PAF109 is
cationic, spans the first loop L1 between β-sheets β1 and β2, and
corresponds to the conserved γ-core motif. PAF118, also with
a positive net charge, includes the β2 and β3 sheets linked by a
small loop (L2). PAF112 extents over the largest surface-exposed
cationic loop L3 of the protein located between β3 and β4. In this
peptide, the central Cys35 in L3 has been replaced by an alanine in
order to promote disulfide bond formation between the terminal
cysteine residues (Figure 2A). An additional peptide derived
FIGURE 1 | Molecular modeling of the P. digitatum class B antifungal protein AfpB. (A) Amino acid sequence alignment of AfpB and P. chrysogenum
antifungal protein PAF. Cysteines are shadowed in black, other conserved amino acids in dark gray, and similar amino acids in light gray. Asterisks below sequences
indicate conserved amino acids and colons similar amino acids. PAF and predicted AfpB β-sheets are labeled as β1 to β5 white arrows; and loops are labeled as L1
to L4. The γ-core motif is boxed. (B) Comparison of the tertiary structure of PAF (right) with the 3D molecular model obtained for AfpB (left).
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FIGURE 2 | Design and in vitro inhibitory activity of the synthetic AfpB-derived peptides. (A) Amino acid sequence and net charge of the AfpB-derived
peptides and their location in the protein sequence. Cysteine residues are shadowed in black. Asterisks and colon show conserved residues (see Figure 1). Arrows
show the predicted β-sheets in AfpB. Black lines show the predicted disulfide bond pattern for AfpB (top) and the disulfide bonds in the AfpB-derived PAF109,
PAF112, PAF118, and PAF119 (bottom). (B) Color-coded location of the AfpB-derived peptides in the modeled tertiary structure of AfpB. (C–F) Color-coded
dose–response curves showing the antimicrobial activity of the peptides PAF109 (red circles), PAF118 (green squares), PAF112 (blue triangles), PAF119 (pink
diamonds), and PAF26 (black circles), tested against P. digitatum (C,E), B. cinerea (D), and E. coli (F). Dose–response curves show mean ± SD percentage of
control growth of triplicate samples after 72 h of incubation at 24◦C for fungi (C–E) and 48 h at 37◦C for bacteria (F).
from this largest surface-exposed cationic loop L3, called PAF113,
was designed. PAF113 corresponds to the linear version of the
peptide PAF112 in which all cysteine residues were substituted by
alanines. Finally, PAF119 has a negative net charge as opposed
to the other three peptides, and includes the last two β-sheets
(β4 and β5) linked by the small C-terminal loop (L4).
These AfpB-derived peptides were tested toward a selection of
filamentous fungi that include plant pathogens (the citrus fruit-
specific P. digitatum, the polyphagous B. cinerea, and the vascular
wilt pathogen F. oxysporum), the PAF producer P. chrysogenum,
and a strain from A. niger particularly sensitive to the PAF
protein. The cationic peptides PAF112 and PAF118 showed
antifungal activity and were completely inhibitory to P. digitatum
and B. cinerea, with MIC values between 64 and 128 µM
(Figures 2C,D and Table 2). At lower concentrations (8–32µM),
PAF112 and PAF118 showed partial inhibition of the growth of
these two fungi (Figure 3 and data not shown). In the case of
A. niger and P. chrysogenum, the PAF112 and PAF118 peptides
significantly delayed fungal growth (Figure 3 and data not
shown). Even at low concentrations (8–32 µM) an inhibition was
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TABLE 2 | Minimum inhibitory concentration (MIC) of peptides studied in this work1.
Microorganism PAF26 PAF109 PAF112 PAF113 PAF118 PAF119 PAF116
P. digitatum CECT20796 8 NI2 64 64 64 NI 32
B. cinerea CECT2100 8 NI 128 128 64 NI 16
F. oxysporum 4287 16 NI NI NI NI NI NI
A. niger CBS 120.49 8 NI >128 >128 >128 NI –3
P. chrysogenum Q176 16 NI >128 >128 >128 NI –
E. coli JM109 NI NI NI NI NI NI –
1MIC values are shown in µM units for each fungus–peptide combination.
2NI, no significant inhibition at the highest concentration tested (128 µM).
3–, not tested.
FIGURE 3 | Time-course inhibition of growth of filamentous fungi by synthetic peptides. Time-course inhibition of growth of P. digitatum (A) and A. niger (B)
in the presence of increasing concentrations of the synthetic peptides PAF26 (2, 4, and 8 µM), PAF112 (8, 32, and 128 µM), and PAF118 (8, 32, and 128 µM). Data
are shown after 24, 48, and 72 h of incubation as indicated. Bars represent the mean value ± SD of the percentage of growth as compared to the 100% control that
was defined for each fungus as the growth in the absence of peptide (C, control) at 72 h.
observed at short incubation times (24 h), although the peptides
were not completely inhibitory at the highest concentration
tested (128 µM) (Figure 3). In some experiments, PAF118
showed slightly higher antifungal activity than PAF112 according
to the dose–response effect (see Figures 2, 3).
Regarding other peptides (Figure 2), PAF109 derived from
the conserved γ-core did not show inhibitory activity at any of
the concentrations tested. The anionic peptide PAF119 did not
show activity either. None of the AfpB-derived peptides tested
showed inhibitory effect against F. oxysporum at the maximum
concentration used. This strain of F. oxysporum has shown
comparatively higher tolerance to most of the peptides studied
in our laboratory over the years (López-García et al., 2015).
The synthetic hexapeptide PAF26 is an antifungal peptide that
was identified by a combinatorial approach against P. digitatum
(López-García et al., 2002). PAF26 is a cationic tryptophan-rich
peptide (Table 1) that belongs to the cell-penetrating class of
AMPs and whose mechanism of action has been characterized
previously (Muñoz et al., 2013a). PAF26 has specific activity
for filamentous fungi showing MIC values below 10 µM and
was therefore chosen as an internal control in this study. We
found that peptides PAF112 and PAF118 are around one order
of magnitude less active than PAF26 (Figure 2E and Table 2).
As occurs with PAF26, none of the AfpB-derived peptides
showed antibacterial activity against E. coli (Figure 2F), which
demonstrated the selective antifungal activity of PAF112 and
PAF118 over the range of concentrations assayed.
Peptide PAF116 Derived from the
P. chrysogenum Antifungal Protein PAF
is Less Active than the Native Protein
Since it was impossible to detect AfpB in all the experiments
conducted so far in our laboratory (Garrigues et al., 2016),
we wanted to test whether peptides derived from AFPs could
have antifungal activity similar to the native protein. Therefore,
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we designed the disulfide cyclized peptide PAF116 analogous
to PAF112 but originating from the P. chrysogenum antifungal
protein PAF, which was readily available (Figure 4). The sequence
alignment of PAF112 and PAF116 showed low similarity (44%;
Figure 4A). However, despite the sequence divergence between
these two peptides, both shared comparable antifungal activity
against P. digitatum (Figure 4B, top). As in the case of PAF112,
PAF116 showed no antifungal activity against F. oxysporum (data
not shown). In contrast, PAF116 exhibited higher antimicrobial
activity than PAF112 against B. cinerea (Table 2).
Additional assays were conducted to compare the antifungal
activity of the peptide PAF116 and the parental protein PAF
(Figure 4B, bottom). The results showed that PAF116 is less
active than the PAF protein against P. digitatum. The MIC values
were 32 µM for the peptide PAF116 and 8 µM for the PAF
protein. This result leads us to propose that AfpB would be
also more active than the peptides PAF112 or PAF118 derived
from its primary sequence. In addition, it is demonstrated that
FIGURE 4 | Comparative study of the AfpB-derived peptide PAF112
and the PAF-derived PAF116. (A) Amino acid sequence alignment of
PAF112 and PAF116. Cysteine conserved residues are shadowed in black,
conserved residues in dark gray, and similar in light gray. Asterisks and colon
show conserved residues (see Figure 1). (B) Dose–response curves of
P. digitatum inhibition by the synthetic peptides PAF112 (blue triangles) and
PAF116 (gray circles) (top), and by the peptide PAF116 (gray circles) and
protein PAF from P. chrysogenum (white triangles) (bottom). Curves show
mean ± SD OD600 of triplicate samples after 72 h of incubation at 24◦C.
P. digitatum is sensitive to the PAF protein from P. chrysogenum,
which as the producer fungus is tolerant to this protein (Table 3).
Synergistic Interactions
In view of the above data we hypothesized that the combined
action of different AfpB-derived peptides could mimic the
activity of the native protein. To address our prediction, we
designed and conducted a series of experiments in which different
peptides were tested for synergy against P. digitatum (Figure 5).
From all possible combinations of the four AfpB-derived peptides
in groups of two, only PAF112 and PAF118 showed positive
synergistic interaction when combined (Figure 5 and data not
shown). A multifactorial ANOVA test was conducted at different
concentrations of PAF112 (from 1 to 32 µM), PAF118 (from 1
to 16 µM) and all possible concentration combinations of both,
demonstrating the existence of an interaction (p < 0.01). As
example, the data from the combined action of 16 µM PAF112
and 1 µM PAF118 is shown (Figure 5, left). Single treatments of
PAF112 or PAF118 did not result in a fungal growth significantly
different from the control. However, the combined activity of
both peptides resulted in significant inhibition of P. digitatum
(p < 0.01, Figure 5), in the range of the inhibition achieved by
the PAF protein at 1µM (Figure 4B). This observation leads us to
suggest that these two motifs contribute to reach optimal activity
of the native AfpB protein.
To determine the possible interaction between the
hexapeptide PAF26 and the antifungal peptides derived from the
AfpB and PAF protein, additional combinations of peptides were
tested. These experiments demonstrated that the AfpB-derived
peptides PAF112 and PAF118, as well as the PAF-derived peptide
PAF116, show a positive synergistic interaction with PAF26
(multifactorial ANOVA, p < 0.01; Figure 5), reducing the fungal
biomass when combined at non-inhibitory concentrations.
Given the synergy existing between PAF26 and the antifungal
peptides derived from both AFPs, further antifungal assays
were conducted to determine whether the protein PAF from
P. chrysogenum could also interact synergistically with PAF26.
Three fungi were chosen for these experiments that are
representative of the sensitivity range to PAF, from the highly
sensitive A. niger to the tolerant PAF-producer P. chrysogenum
(Table 3). The results indicated no apparent synergy in assays
with P. chrysogenum. For P. digitatum and the highly PAF-
sensitive A. niger, PAF protein showed a positive synergistic
interaction with the peptide PAF26 (Figure 6 and Table 3).
Interestingly, the three fungi did not show major differences in
their sensitivity to PAF26 while they did to the PAF protein
(Table 3), suggesting that the PAF protein and the peptide PAF26
could have differences in their mechanism of action.
ECD Spectroscopic Analysis
Electronic circular dichroism spectroscopy is a sensitive tool for
the study of the secondary structure of proteins and peptides.
To investigate the structure of the AfpB-derived peptides, ECD
spectroscopy was performed (Figure 7). ECD analyses revealed
that peptides PAF109, PAF112, and PAF113 predominantly
displayed unordered structure in water characterized by strong
minima at 195–200 nm (Figure 7A). TFE is an organic solvent
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TABLE 3 | Synergistic interaction between PAF26 peptide and PAF protein.
Strain PAF26 peptide1 PAF protein1 Interaction PAF26/PAF
P. digitatum CECT20796 8 8 Positive synergy (p < 0.01)
P. chrysogenum Q176 16 NI2 No synergy
A. niger CBS 120.49 8 0.08 Positive synergy (p < 0.01)
1MIC (µM) are shown for each combination.
2NI, no inhibition at the highest concentration tested (64 µM).
FIGURE 5 | Synergistic interactions between AFP-derived peptides and PAF26. Each of the four panels show the synergistic interactions between PAF112
and PAF118; PAF112 and PAF26; PAF118 and PAF26; and PAF116 and PAF26, tested against P. digitatum. The graphics show mean ± SD OD600 values of
triplicate samples after 48 h of incubation at 24◦C. Asterisks show statistical significance for positive interaction (multifactorial ANOVA p < 0.01) of fungal growth
inhibition for each peptide combination at the concentrations indicated below the panels.
FIGURE 6 | Synergistic interactions between the protein PAF from P. chrysogenum and the hexapeptide PAF26. The synergistic interaction was tested
against P. digitatum (A) and A. niger (B). The graphics show mean ± SD OD600 values of triplicate samples after 48 h of incubation at 24◦C. Asterisks show
statistical significance for positive interaction (multifactorial ANOVA p < 0.01) of fungal growth inhibition for each peptide/protein combinations at the concentrations
indicated below the panels.
commonly used to induce intramolecular H-bonding, therefore
inducing and stabilizing secondary structure of protein fragments
in the absence of cooperatively stabilizing structural regions of
the protein of origin. Upon addition of TFE, a minor helical
contribution appeared in case of the linear peptide PAF113,
reflected by a low intensity broad negative shoulder in the
220–225 nm region (Figure 7B). Since this peptide has no
disulfide bond and therefore less conformational restraints, it
can adapt more readily to changes in environment (for example,
addition of a helix-inducing solvent). PAF119 (Figure 7A)
yielded a spectrum that reports on the dominance of random
structures with a minor β-sheet contribution, and a more
pronounced signal from the disulfide bridge (maximum around
230 nm). Addition of TFE to PAF119 did not increase, but rather
diminished β-sheet contributions.
PAF118 displayed markedly different spectra compared to
those of the rest of the peptides analyzed (Figure 7A, green line).
The ECD spectrum of PAF118 is dominated by contributions
from antiparallel β-structure (relative maximum near 195 nm
and minimum near 215 nm) and disulfide bonds (maximum
at 230 nm). Addition of TFE increased the β-character of the
spectrum while the presence of a positive band at around
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FIGURE 7 | ECD spectra of AfpB-derived peptides. (A) Spectra obtained
from peptides in H2O. (B) Spectra obtained from peptides solved in TFE/H2O
(50:50) mixture. All experiments were conducted at 25◦C.
230 nm indicative of disulfide bonds was maintained (Figure 7B).
Therefore, PAF118 represents an antifungal motif from AfpB that
folds by itself in an antiparallel β-structure, consistent with the
structural prediction within the context of the protein (see also
Figure 2B).
AfpB-Derived Peptides Show Resistance
to Proteolytic Degradation
To exclude the possibility that increased sensitivity to proteolytic
degradation could be the reason for limited antifungal activity,
we tested the in vitro stability of the peptides derived from
AfpB by incubation with proteinase K at different times and
RP-HPLC analysis of the resultant digests. Again, we used
peptide PAF26 as control as it is considered highly resistant
to protease degradation (López-García et al., 2015). The RP-
HPLC chromatograms (Supplementary Figure S3) showed that
all the cyclic peptides derived from AfpB were, with varying
degrees, resistant to protease treatment with a high dose of
enzyme (5 µg/mL) (Figure 8). The antifungal peptides PAF112
and PAF118 show a degradation pattern similar to PAF26, with
FIGURE 8 | Time-dependent peptide degradation in the presence of
proteinase K. Percentage of recovery of the input peptides (5 µM)
represented as mean ± SD of two replicates, determined by the resulting
chromatographic peak area of the corresponding peptide after treatment with
proteinase K (5 µg/mL) for different times (0, 1, 2, and 24 h).
around 20% of peptide left after 24 h of treatment. Consistently
among the different repetitions of this experiment, PAF118
showed faster degradation than PAF112. Figure 8 shows a severe
reduction of intact PAF118 after 1 and 2 h of treatment, which
was different to the degradation of PAF112. Despite their similar
antifungal activities and the presence of a disulfide bond in
both sequences, PAF112 seems to be more resistant to protease
degradation than PAF118. PAF113, which is a linear analog
of PAF112, shows high sensitivity to proteinase K as it was
completely degraded after only 1 h of treatment (Figure 8).
We conclude that the presence of a disulfide bond increases
PAF112 stability. Finally, the non-active peptides PAF109 and
specially PAF119 were both remarkably resistant to degradation
by proteinase K (Figure 8).
DISCUSSION
Most of the studies based on peptides derived from antifungal
CRPs have focused on defensins and the highly conserved
γ-motif (Sagaram et al., 2011; Avitabile et al., 2013; van der
Weerden and Anderson, 2013; Muñoz et al., 2014; Kaewklom
et al., 2016), but not on fungal AFPs. Our data identify for
the first time synthetic peptides derived from fungal AFPs with
antifungal activity. The peptides PAF112 and PAF118 derived
from the P. digitatum AfpB and PAF116 from the P. chrysogenum
PAF showed specific activity against selected filamentous fungi.
PAF112 and PAF118 are not active against bacteria (E. coli) at
the highest concentration tested (128 µM, Figure 2), which is
consistent with the specificity profile of native AFPs that are
antifungal but not antibacterial (Marx et al., 2008; Meyer, 2008).
Importantly, none of the peptides overlap in neither of the two
AFPs with the conserved γ-core motif that is present in virtually
all known AFPs and other defensin-like antimicrobial peptides
(Yount and Yeaman, 2004). There is no correlation between the
GRAVY value and the activity of the peptides designed in our
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study, while all the active peptides are cationic (Tables 1, 2). The
importance of positive charge in the activity of AMPs including
AFPs is well established (Brogden, 2005; Marcos et al., 2008). For
example, three different mutations of the P. chrysogenum PAF
in cationic lysine residues located at different positions resulted
in loss of antifungal activity (Batta et al., 2009), and mutation
of the arginine and/or lysine residues in the PAF26 sequence
also abolished activity (Muñoz et al., 2013a). However, PAF112
and PAF116 show similar antifungal activity despite differences
in charge (i.e., PAF116 is markedly more cationic). Therefore,
the antifungal activity of these peptides can only be partially
attributed to their positive net charge (see also below).
The P. chrysogenum PAF is the antifungal protein that has
been most extensively characterized by site-directed mutagenesis,
which allowed the identification of residues important for activity
(Batta et al., 2009; Sonderegger et al., 2016, 2017). Both PAF112
and PAF116 are located in the analogous large loop L3 of the
corresponding class B protein AfpB and class A protein PAF,
respectively. Although these peptides share only limited sequence
identity, they represent one of the regions with highest similarity
between both proteins. Mutations of Lys35 and Lys38 (Batta
et al., 2009) and of Phe31 (Sonderegger et al., 2016), which are
located in this L3 loop of P. chrysogenum PAF, negatively affect
antifungal activity. Therefore, by demonstrating the activity of
isolated peptides from two different proteins (AfpB and PAF),
our study contributes to establish L3 as an important domain
in the antifungal activity of this class of AMPs. The peptide
PAF112 is not structured (Figure 7), simulating the situation in
the exposed loop L3 of the protein model, which lacks a defined
canonical secondary structure (Figures 1, 2). The structural data
have shown that loop L3 is a dynamic and flexible region in PAF
(Batta et al., 2009; Fizil et al., 2015).
The antifungal peptide PAF118 folds into an antiparallel
β-sheet conformation that resembles the folding of this motif
within the context of the protein. None of the previously reported
mutations in residues of the PAF protein that affect the protein
activity locate in the protein region analogous to PAF118 (Batta
et al., 2009; Sonderegger et al., 2016). However, very recently
it has been shown that the exchange of the negatively charged
Asp19 to a neutral Ser in this PAF protein domain severely
reduced protein activity (Sonderegger et al., 2017). This mutation
does not disturb the overall 3D protein solution structure, but
influences the surface charge distribution in distant regions of
the PAF protein including the cationic L3, which most probably
accounts for the loss of antifungal function (Sonderegger et al.,
2017). The primary sequence of PAF and AfpB is different in this
region as for instance no anionic residues are present in AfpB,
contrary to PAF. Our demonstration of activity of the isolated
motif represented by PAF118 identify this as a second putative
region involved in the activity of AfpB. The only two cationic
residues in this peptide are located in the turn that connects the
two antiparallel β-sheets, and represent candidates to determine
the antifungal properties of PAF118. Future work will attempt to
confirm the importance of this domain in the activity of AFP-like
proteins.
On the other hand, PAF109, which contains the minimal
γ-core element, did not show either antifungal or antibacterial
activity with any of the microorganism tested in our study.
Consistent with the archetypical γ-core motif (Yount and
Yeaman, 2004), this peptide sequence spans two antiparallel
β-sheets (Figure 2B). Plant defensins are related to AFPs in that
they are small and cationic CRPs that have antifungal activity and
contain the γ-core motif; however, their αβ fold is structurally
distinct from that of AFPs (van der Weerden and Anderson,
2013; Silva et al., 2014). Analogous γ-core peptides from the
plant defensins MtDef4 from Medicago, SolyC07g007760 from
tomato, or BhDef2 from Brassica were antimicrobial (Sagaram
et al., 2011; Avitabile et al., 2013; Kaewklom et al., 2016).
However, other γ-core peptides such as the two motifs derived
from the Medicago defensin MsDef1 did not show antifungal
activity against Fusarium graminearum (Sagaram et al., 2011). In
previous studies, a correlation between the cationic net charge
of the γ-core-derivative peptides and their antimicrobial activity
was demonstrated. The peptide derivative BhDEF12M from
BhDef1 protein contains asparagine to arginine substitutions that
promoted antibacterial and antifungal activity (Kaewklom et al.,
2016). Yet, there are exemptions to this rule as other non-cationic
γ-core peptides derived from plant defensins (i.e., BhDef23) were
antimicrobial (Kaewklom et al., 2016). In this context, PAF109
is a peptide that has low positive charge (ca. +1.1 at pH 7.0)
and did not show activity. In addition, PAF109 and PAF119 are
extremely stable peptides. Based on our data, we propose that
the γ-core in AfpB has mainly a structural significance important
for the formation of the native structure and the stability of
the protein but is not necessarily associated with antimicrobial
activity. However, the γ-core in the P. chrysogenum PAF has a
higher cationic charge than the AfpB γ-core and mutation of Lys9
in the PAF protein resulted in the decrease of protein activity
suggesting that this motif is important for protein function (Batta
et al., 2009). Future investigations will address this apparently
contradictive issue in fungal AFPs.
Antifungal activity of PAF116 is about 5–10 times weaker
than the activity of the corresponding PAF protein. This finding
implicates that additional motifs/sequences in the protein are
required to achieve full activity. Similarly, we predict that PAF112
and PAF118 also have significantly lower activity than the elusive
(non-detectable) AfpB. In order to test this hypothesis, our
current efforts are directed toward the heterologous expression of
the afpB gene to achieve protein production and purification. As
an alternative approach in this study, we conducted experiments
to determine whether treatment with both PAF112 and PAF118
inhibits fungal growth with potency higher than the sum of both
peptides acting individually. We could demonstrate a positive
synergistic interaction (Figure 5), which supports our hypothesis
that both domains could cooperate to achieve the activity of the
full-length protein.
It is generally established that antimicrobial compounds that
have a positive synergistic interaction act on different microbial
targets or have mechanisms of action that complement each
other (Glattard et al., 2016; Vriens et al., 2016). This would be
the case for the different AFP-derived and PAF26 peptides on
P. digitatum and also for the PAF26/PAF protein combination
on A. niger and P. digitatum as described in this study.
Different time-course inhibition by PAF26 or AfpB-derived
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peptides on either P. digitatum or A. niger indicate mechanistic
differences (Figure 3). The existence of at least partially different
mechanisms in the combination PAF26/PAF protein is also
supported by the different profile of activity among different
fungal strains (Table 3). Furthermore, the demonstration
of synergy also opens up new alternatives to improve (i)
the antifungal activity of AFPs by combined action with
other unrelated peptides such as PAF26, or (ii) the rational
design of novel AMPs by combination of distinct peptide
sequences (Badosa et al., 2009; Rodriguez Plaza et al.,
2014).
Besides, there are also common mechanistic features between
AFP proteins and the unrelated synthetic peptide PAF26, such
as the endocytic internalization and increased concentrations
of intracellular reactive oxygen species and cytoplasmic Ca2+
in sensitive fungal cells (Marx et al., 2008; Binder et al., 2010;
Carmona et al., 2012; Muñoz et al., 2012). PAF26 has been
proposed as a model peptide to study the mode of action of
cell penetrating antifungal peptides (Muñoz et al., 2013a,b).
The mechanism of PAF26 has been divided in three stages: (i)
interaction with the fungal cell surface (cell wall and membrane),
(ii) cellular internalization, and (iii) intracellular killing. This
model framework could be useful to better refine and characterize
the mechanism of AFPs and related proteins. Additionally, the
identification of PAF112, PAF118, and PAF116 provides minimal
motifs useful for the detailed mechanistic study of AFP-like
proteins.
AFPs show remarkable thermal stability and resistance
to protease degradation, which has been attributed to their
tight structural packaging and disulfide bonding (Batta et al.,
2009; Fizil et al., 2015). Consistently with this, all the AfpB-
derived peptides with disulfide bonds were stable under
restrictive in vitro degradation experiments (Figure 8). The
stability of PAF109 and PAF119 indicates that their lack
of antifungal activity cannot be attributed to propensity
to degradation. By characterizing the linear analog PAF113
of peptide PAF112 we confirmed that the disulfide bridge
between the two cysteines greatly stabilizes the peptide toward
proteolytic degradation by proteinase K (Avitabile et al., 2013).
PAF113 shows initial antifungal activity comparable to PAF112,
although the activity was gradually lost with time in some
experiments (data not shown), probably as consequence of
degradation. The stability of all four cyclized AfpB-derived
peptides suggests a reasonable stability of the putative protein
AfpB. In that case, other so far unidentified regulatory
mechanisms in mRNA stability and/or protein translation could
be responsible for the lack of AfpB detection in P. digitatum
cultures.
In summary, this study identifies protein motifs involved in
the specific antifungal activity of AFPs, and opens new strategies
for the future use of AFP-related peptides and proteins, the
development of rationally designed antifungal peptides and their
use in the characterization of the antifungal activity of AFPs.
Two synthetic peptides that span about the central half of
AfpB, including the major L3 loop, would contribute to specific
antifungal activity of the putative AfpB, whereas the γ-core motif
seems to play a different functional role.
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